- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02889588
Visual and Optics Impact of Refractive Surgery (CRIVO)
March 26, 2018 updated by: Fondation Ophtalmologique Adolphe de Rothschild
Refractive surgery includes interventions to correct refractive errors, using a medical device such as a laser or an implant (intraocular lenses) or surgical instruments.
The study distinguishes corneal interventions, carried on the surface of the eye, and intraocular interventions, performed on the lens or in the anterior or posterior chamber of the eye.
The number of procedures in refractive surgery is growing significantly.
They seem to offer satisfactory visual results but a number of issues remains unresolved.
In order to get emmetropia, refractive surgery corrects optical defects by decreasing aberrations of lower orders (ie spherical refractive error and astigmatism).
This increases high-order aberrations (the most common is a bright halo on the edge of the image).
The cutting of the flap to the surface of the cornea in the case of LASIK increases high-order aberrations, which have the effect of reducing post-surgical visual performance (ie visual acuity and contrast sensitivity) and can't be corrected by glasses, while the adaptation of contact lenses on a post-operative cornea is more complex.
It is therefore necessary to limit these post-surgical aberrations and to identify their possible sources.
Indeed, some authors have provided insight into the effects of some high-order aberrations, but the influence of several factors characterizing the preoperative eye on refractive surgery are still unknown, such as pupillary diameter, depth of the anterior chamber, Intra Ocular Pressure or astigmatism.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Paris, France, 75019
- Fondation Ophtalmologique Adolphe de Rothschild
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients undergoing refractive surgery
Description
Inclusion Criteria:
- patient candidate for Laser in Situ Keratomileusis (LASIK) refractive surgery
- 18 to 40 years old
- corrective glasses or lenses ranging from -9.00 to + 6.00 diopter
- astigmatism less than or equal to 5 diopter
Exclusion Criteria:
- patient opposition to participate in the study
- patient under legal protection
- Pregnant or breast feeding patient
- no health insurance coverage
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
number of high order aberrations after refractive surgery
Time Frame: 3 months after baseline
|
3 months after baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Imène SALAH, Fondation OPH A de Rothschild
- Principal Investigator: Damien GATINEL, MD, Fondation OPH A de Rothschild
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 1, 2015
Primary Completion (ACTUAL)
August 31, 2017
Study Completion (ACTUAL)
March 15, 2018
Study Registration Dates
First Submitted
August 31, 2016
First Submitted That Met QC Criteria
August 31, 2016
First Posted (ESTIMATE)
September 5, 2016
Study Record Updates
Last Update Posted (ACTUAL)
March 27, 2018
Last Update Submitted That Met QC Criteria
March 26, 2018
Last Verified
March 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DGL_2015_20
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Refractive Disorders
-
Asociación para Evitar la Ceguera en MéxicoTerminated
-
Essilor InternationalRecruitingChildren | Astigmatism | Refractive Assessment | Refractive Disorders | Refractive Error Correction | Hyperopia and MyopiaPortugal
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
GCS Ramsay Santé pour l'Enseignement et la RechercheRecruitingRefractive DisordersFrance
-
Holhos Larisa BiancaCompleted
-
Instituto de Olhos de GoianiaCompletedRefractive and Accommodative Disorders
-
Johns Hopkins UniversityNational Health and Medical Research Council, AustraliaCompletedAstigmatism | Myopia | HyperopiaChina, India
-
Suzan A RattanCompletedRefractive Errors | Refractive SurgeryIraq